SCHEMBL607804

SCHEMBL607804

C=C(C)N1CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL610675 0.97 ALDH1A1 (0.41)
SCHEMBL609091 0.97
SCHEMBL22762181 0.97 ALDH1A1 (0.41)
SCHEMBL11055329 0.93
Acetic Acid SCHEMBL30330000 0.89 ALDH1A1 (0.42)
SCHEMBL7863270 0.86
Trifluoromethanesulfonic Acid SCHEMBL30330016 0.79 MLYCD (0.31)
SCHEMBL18944380 0.79 HTT (0.47)
SCHEMBL16977024 0.77 CA2 (0.45)
SCHEMBL25045002 0.75 MEN1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0586476-B1 METHOD OF PRODUCING REPRODUCIBLE PARTICLES MEDINVENT SA (SE) 1996-03-27 EP claimed
EP-4223754-A1 COMPOUND AS AKT KINASE INHIBITOR CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) 2023-08-09 EP disclosed
CN-110248949-B Immunoproteasome inhibitors 普林斯匹亚生物制药公司 2023-02-17 CN disclosed
WO-2022261243-A1 COMBINATION THERAPIES WITH SETD2 INHIBITORS Epizyme, Inc. (US) 2022-12-15 WO disclosed
WO-2022087624-A1 COMPOUNDS AS RAS INHIBITORS AND USES THEREOF BIOARDIS LLC (US) 2022-04-28 WO disclosed
US-11052092-B2 N-{[2-(piperidin-1-yl)phenyl](phenyl)methyl}-2-(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl)acetamide derivatives and related compounds as ROR-gamma modulators for treating autoimmune diseases GENFIT (FR) 2021-07-06 US disclosed
EP-3377060-B1 PYRAZOLE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND USES THEREOF LUNDBECK LA JOLLA RESEARCH CENTER INC (US) 2020-08-19 EP disclosed
EP-3239183-B1 MODIFIED CONJUGATED DIENE POLYMER, AND POLYMER COMPOSITION CONTAINING SAID POLYMER SUMITOMO CHEMICAL CO (JP) 2020-03-11 EP disclosed
US-20190256494-A1 PYRAZOLE COMPOUNDS AND METHODS OF MAKING AND USING SAME H. LUNDBECK A/S (DK) 2019-08-22 US disclosed
US-10118973-B2 Modified conjugated diene polymer, and polymer composition containing said polymer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-11-06 US disclosed
WO-2009100095-A1 3-(4-FLUOROPHENYL)-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES AND RELATED COMPOUNDS HAVING ANALGESIC ACTIVITY ALLERGAN, INC. (US) 2009-08-13 WO disclosed
US-20080095806-A1 Composition And Method For Treating Inflammatory Diseases Using Protease Inhibitors PROMETIC BIOSCIENCES, INC. (CA) 2008-04-24 US disclosed
WO-2007121920-A2 PURINE DERIVATIVES FOR USE AS ADENOSIN A2A RECEPTOR AGONISTS NOVARTIS AG (CH) 2007-11-01 WO disclosed
US-7208139-B2 Conducting nuclear spin tomography on a patient who has been administered a cascade polymer complex having complex-forming ligands for imaging of inflammation and/or tumors in the brain SCHERING AG (DE) 2007-04-24 US disclosed
US-20070066674-A1 Tricyclic imidzopyridines for use as gastric secretion inhibitors ALTANA PHARMA AG (DE) 2007-03-22 US disclosed
WO-2005117955-A1 TREATMENT OF ATOPIC DERMATITIS WITH UNGLYCOSYLATED ALPHA ONE-ANTITRYPSIN ARRIVA PHARMACEUTICALS, INC. (US) 2005-12-15 WO disclosed
EP-1562621-A1 COMPOSITION AND METHOD FOR TREATING INFLAMMATORY DISEASES USING PROTEASE INHIBITORS Arriva-Prometic Inc. (CA) 2005-08-17 EP disclosed
WO-2004045634-A1 COMPOSITION AND METHOD FOR TREATING INFLAMMATORY DISEASES USING PROTEASE INHIBITORS ARRIVA-PROMETIC INC. (CA) 2004-06-03 WO disclosed
US-4956107-A OIL ADDITIVE COMPRISING POLYOLEFIN MODIFIES BY AN UNSATURATED MONOCARBOXYLIC ACID AND THE REACTION PRODUCT OF A POLYAMINE AND ESTER, THIOESTER, AMIDE OR THIOAMIDE EXXON CHEMICAL PATENTS INC. (US) 1990-09-11 US disclosed
US-4238609-A Production of ampho-ionic compounds NIPPON PAINT CO., LTD. (JP) 1980-12-09 US disclosed